Table 1.
Demographic and pathophysiological characteristics of study patients
| Characteristic | Statistics results |
|---|---|
| Male/female n | 49/21 |
| AGE/(years) (mean ± SD) | 78.3 ± 6.96 |
| Height/cm (mean ± SD) | 161 ± 10 |
| WT/kg (mean ± SD) | 60.7 ± 10.2 |
| Daily dose/g/day (mean ± SD) | 1.55 ± 0.770 |
| Serum concentration/mg/L (mean ± SD) | 17 ± 8.03 |
| SCR/μmol/L (mean ± SD) | 90.6 ± 31 |
| CLCR/mL/min (mean ± SD) | 56.3 ± 22.1 |
| BUN/mmol/L (minimum–maximum) | 10.5 (3.18–86) |
| TP/g/dL (mean ± SD) | 59.8 ± 8.92 |
| ALB/g/dL (mean ± SD) | 29.3 ± 4.12 |
| HAP n (%) | 57 (81.4%) |
| CAP n (%) | 13 (18.6%) |
| Respiratory failure n (%) | 46 (65.7%) |
| Hypertension n (%) | 38 (54.3%) |
WT weight, SCR serum creatinine, CLCR creatinine clearance rate, BUN blood urea nitrogen, TP total protein, ALB albumin, HAP hospital-acquired pneumonia, CAP community-acquired pneumonia